AbCellera Biologics Inc. (ABCL)
USD 2.69
(-3.58%)
USD 2.69
(-3.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -43.87 Million | 277.36 Million | 244.58 Million | 22.69 Million | 2.69 Million | 3.56 Million |
| Net Income | -146.39 Million | 158.51 Million | 153.46 Million | 118.91 Million | -2.21 Million | 309 Thousand |
| Depreciation & Amortization | 30.89 Million | 33.1 Million | 17.25 Million | 5.27 Million | 1.84 Million | 918 Thousand |
| Deferred income taxes | 1.96 Million | -2.11 Million | -2.01 Million | 2.09 Million | - | - |
| Stock-based compensation | 64.18 Million | 49.48 Million | 30.64 Million | 8.39 Million | 890.23 Thousand | 615 Thousand |
| Change in working capital | 13.22 Million | 29.82 Million | 41.67 Million | -116.7 Million | 1.97 Million | 1.91 Million |
| Other non-cash items | -7.74 Million | 8.54 Million | 3.57 Million | 4.7 Million | 194.19 Thousand | -188 Thousand |
| Investing Cash Flow | -221.1 Million | -352.62 Million | -332.24 Million | -119.78 Million | -5.77 Million | -5.3 Million |
| Investments in PPE | -77.5 Million | -72.66 Million | -58.45 Million | -14.67 Million | -3.99 Million | -5.3 Million |
| Acquisitions | -13.69 Million | -25.67 Million | -41.78 Million | -106.89 Million | - | - |
| Investment purchases | -1.06 Billion | -781.35 Million | -292.24 Million | -19.24 Million | - | - |
| Sales/Maturities of investments | 910.93 Million | 510.63 Million | 27.6 Million | 19.24 Million | - | - |
| Other Investing Activities | 25.31 Million | 16.43 Million | 32.62 Million | 1.78 Million | -1.78 Million | - |
| Financing Cash Flow | 10.35 Million | -1.62 Million | -3.88 Million | 683.65 Million | 194.82 Thousand | 12.18 Million |
| Debt repayment | -11.59 Million | -2.75 Million | -1.82 Million | -19.94 Million | -399.06 Thousand | -899 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -11.15 Thousand | - |
| Common Stock Issuance | - | - | 4.61 Million | 522.84 Million | 14.16 Thousand | 2.61 Million |
| Other Financing Activities | -1.23 Million | -4.38 Million | -6.67 Million | 180.75 Million | 605.04 Thousand | 10.47 Million |
| Accounts receivables | -45.93 Million | -22.71 Million | -37.38 Million | -5.46 Million | -1.8 Million | -477 Thousand |
| Accounts payables | -15.1 Million | 1.06 Million | 1.4 Million | 6.6 Million | 150.09 Thousand | 180 Thousand |
| Inventory | 18.25 Million | - | 40.91 Million | -134.34 Million | -150.09 Thousand | -897.77 Thousand |
| Other working capital | 56 Million | 51.47 Million | 36.73 Million | 16.51 Million | 3.77 Million | 3.1 Million |
| Cash at beginning of period | 414.65 Million | 501.14 Million | 594.11 Million | 7.55 Million | 10.44 Million | -283.00 |
| Cash at end of period | 160.61 Million | 414.65 Million | 501.14 Million | 594.11 Million | 7.55 Million | 10.44 Million |
| Capital Expenditure | -77.5 Million | -72.66 Million | -58.45 Million | -14.67 Million | -3.99 Million | -5.3 Million |
| Effect of forex changes on cash | 589 Thousand | -9.59 Million | -1.42 Million | - | - | 283.00 |
| Net cash flow / Change in cash | -254.04 Million | -86.49 Million | -92.97 Million | 586.56 Million | -2.89 Million | 10.44 Million |
| Free Cash Flow | -121.38 Million | 204.7 Million | 186.13 Million | 8.01 Million | -1.3 Million | -1.74 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.1 Million | -36.93 Million | -40.61 Million | -47.15 Million | -146.39 Million | -28.61 Million |
| Depreciation & Amortization | 33.48 Million | 38.03 Million | 6.76 Million | 9.1 Million | 30.89 Million | 7.4 Million |
| Deferred income taxes | - | - | - | 1.96 Million | 1.96 Million | - |
| Stock-based compensation | 17.16 Million | 17.78 Million | 17.4 Million | 16.44 Million | 64.18 Million | 15.86 Million |
| Change in working capital | 34.76 Million | -7.78 Million | -26.98 Million | 1.4 Million | 13.22 Million | 7.15 Million |
| Other non-cash items | -63.69 Million | 64.16 Million | 56.1 Million | -1.38 Million | -7.74 Million | -1.92 Million |
| Investing Cash Flow | 4.27 Million | 51.51 Million | 29.91 Million | -24.32 Million | -221.1 Million | -12.78 Million |
| Investments in PPE | -18.82 Million | -19.79 Million | -24.14 Million | -14.43 Million | -77.5 Million | -20.89 Million |
| Acquisitions | 10.82 Million | -4.91 Million | -5.9 Million | -3.47 Million | -13.69 Million | -3.54 Million |
| Investment purchases | -178.51 Million | -174.07 Million | -259.66 Million | -284.72 Million | -1.06 Billion | -215.78 Million |
| Sales/Maturities of investments | -539.48 Million | 232.94 Million | 306.54 Million | 268.02 Million | 910.93 Million | 220.09 Million |
| Other Investing Activities | 730.29 Million | 12.44 Million | 7.16 Million | 10.28 Million | 25.31 Million | 7.33 Million |
| Financing Cash Flow | 3.18 Million | 2.61 Million | 2.83 Million | 3.76 Million | 10.35 Million | 6.63 Million |
| Debt repayment | -4.46 Million | -2.34 Million | -2.12 Million | -3.95 Million | -11.59 Million | -7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.34 Million | 451.42 Thousand | 892 Thousand | - | - | - |
| Other Financing Activities | 8.99 Million | -180.39 Thousand | -185 Thousand | -185 Thousand | -1.23 Million | -372 Thousand |
| Accounts receivables | 34.19 Million | -15.61 Million | -18.57 Million | -10.43 Million | -45.93 Million | -11.22 Million |
| Accounts payables | 4.14 Million | 4.74 Million | -4.87 Million | -13.25 Million | -15.1 Million | 975 Thousand |
| Inventory | - | - | - | -7.77 Million | 18.25 Million | 14.96 Million |
| Other working capital | 447.8 Thousand | 3.07 Million | -3.52 Million | 32.87 Million | 56 Million | 2.44 Million |
| Cash at beginning of period | 173.31 Million | 148.57 Million | 159.92 Million | 199.71 Million | 414.65 Million | 207.03 Million |
| Cash at end of period | 153.93 Million | 173.31 Million | 148.57 Million | 160.61 Million | 160.61 Million | 199.71 Million |
| Capital Expenditure | -18.82 Million | -19.79 Million | -24.14 Million | -14.43 Million | -77.5 Million | -20.89 Million |
| Effect of forex changes on cash | 367 Thousand | -43 Thousand | -781 Thousand | 1.06 Million | 589 Thousand | -1.06 Million |
| Net cash flow / Change in cash | -19.38 Million | 24.74 Million | -11.34 Million | -39.1 Million | -254.04 Million | -7.32 Million |
| Free Cash Flow | -48.21 Million | -49.25 Million | -65.84 Million | -34.04 Million | -121.38 Million | -20.99 Million |
SBRY
8119
600592
088790
MCO
2883